BPC-157

Last Updated: September 28 2022

BPC-157 is a synthetic peptide that is being investigated for its regenerative effects. It shows high efficacy for rats suffering toxic or surgical trauma, but there is currently no evidence that it provides benefits for people.

BPC-157 is most often used for

Summary

BPC-157 is a peptide chain consisting of 15 amino acids. It is considered synthetic because this particular sequence does not exist in nature. It is derived from a protective protein found in the stomach.

Researchers have conducted numerous rodent studies on BPC-157 that show it has protective effects extending beyond the stomach and intestinal tract. BPC-157 has been shown to benefit ulcers in the stomach, intestinal damage such as fistulas and inflammatory disorders, bone and joint healing and growth rates, and organ damage. It also has some influences on the brain. Researchers have observed marked protective effects when BPC-157 is administired to rats alongside a research toxin or damaging surgical procedure.

More research is needed to clarify whether BPC-157 has multiple mechanisms of action, but current research suggests BPC-157 influences several growth factors usually involved in angiogenesis (the production of blood vessels) and other factors involved in regeneration following damage.

BPC-157 shows promise, but human studies are needed to demonstrate that these benefits extend beyond research animals.

The majority of studies on BPC-157 are done on rats given injections of the supplement. While BPC-157 is a stable peptide, peptides are a group of compounds that are normally poorly absorbed after oral supplementation, so researchers use injections in rodent studies instead. Furthermore, there is no human evidence for BPC-157 and the majority of the research has been conducted by a single research group. Due to its synthetic nature, there may be legal issues associated with the sale of this supplement in certain regions and it may be banned by some sport organizations.

What else is BPC-157 known as?
Note that BPC-157 is also known as:
  • PL 14736
  • PL-10
  • Bepecin
BPC-157 should not be confused with:
  • TB-500
Dosage information

The closest possible recommended dose is based on rat studies where oral administration showed benefit, as most studies administer the supplement via injection. The oral dose that was effective in rats, 10 μg/kg, is estimated to be equivalent to 1.6 μg/kg, or:

  • 110 μg for a 150lb person
  • 145 μg for a 200lb person
  • 180 μg for a 250lb person

There are currently no human pharmacokinetic studies to assess species differences.

References
2.^Jelovac N, Sikirić P, Rucman R, Petek M, Perović D, Konjevoda P, Marović A, Seiwerth S, Grabarević Z, Sumajstorcić J, Dodig G, Perić JA novel pentadecapeptide, BPC 157, blocks the stereotypy produced acutely by amphetamine and the development of haloperidol-induced supersensitivity to amphetamineBiol Psychiatry.(1998 Apr 1)
3.^Cox HD, Miller GD, Eichner DDetection and in vitro metabolism of the confiscated peptides BPC 157 and MGF R23HDrug Test Anal.(2016 Dec 29)
4.^Tkalcević VI, Cuzić S, Brajsa K, Mildner B, Bokulić A, Situm K, Perović D, Glojnarić I, Parnham MJEnhancement by PL 14736 of granulation and collagen organization in healing wounds and the potential role of egr-1 expressionEur J Pharmacol.(2007 Sep 10)
5.^Sikiric P, Separovic J, Buljat G, Anic T, Stancic-Rokotov D, Mikus D, Marovic A, Prkacin I, Duplancic B, Zoricic I, Aralica G, Lovric-Bencic M, Ziger T, Perovic D, Rotkvic I, Mise S, Hanzevacki M, Hahn V, Seiwerth S, Turkovic B, Grabarevic Z, Petek M, Rucman RThe antidepressant effect of an antiulcer pentadecapeptide BPC 157 in Porsolt's test and chronic unpredictable stress in rats. A comparison with antidepressantsJ Physiol Paris.(2000 Mar-Apr)
6.^Veljaca M, Lesch CA, Pllana R, Sanchez B, Chan K, Guglietta ABPC-15 reduces trinitrobenzene sulfonic acid-induced colonic damage in ratsJ Pharmacol Exp Ther.(1995 Jan)
7.^Hsieh MJ, Liu HT, Wang CN, Huang HY, Lin Y, Ko YS, Wang JS, Chang VH, Pang JSTherapeutic potential of pro-angiogenic BPC157 is associated with VEGFR2 activation and up-regulationJ Mol Med (Berl).(2017 Mar)
10.^Rebec GV, Peirson EE, McPherson FA, Brugge KDifferential sensitivity to amphetamine following long-term treatment with clozapine or haloperidolPsychopharmacology (Berl).(1982)
11.^Sikiric P, Jelovac N, Jelovac-Gjeldum A, Dodig G, Staresinic M, Anic T, Zoricic I, Rak D, Perovic D, Aralica G, Buljat G, Prkacin I, Lovric-Bencic M, Separovic J, Seiwerth S, Rucman R, Petek M, Turkovic B, Ziger T, Boban-Blagaic A, Bedekovic V, Tonkic A, Babic SPentadecapeptide BPC 157 attenuates chronic amphetamine-induced behavior disturbancesActa Pharmacol Sin.(2002 May)
12.^Sikiric P, Seiwerth S, Rucman R, Kolenc D, Vuletic LB, Drmic D, Grgic T, Strbe S, Zukanovic G, Crvenkovic D, Madzarac G, Rukavina I, Sucic M, Baric M, Starcevic N, Krstonijevic Z, Bencic ML, Filipcic I, Rokotov DS, Vlainic JBrain-gut Axis and Pentadecapeptide BPC 157: Theoretical and Practical ImplicationsCurr Neuropharmacol.(2016)
13.^Jenkins TA, Nguyen JC, Polglaze KE, Bertrand PPInfluence of Tryptophan and Serotonin on Mood and Cognition with a Possible Role of the Gut-Brain AxisNutrients.(2016 Jan 20)
15.^Klicek R, Kolenc D, Suran J, Drmic D, Brcic L, Aralica G, Sever M, Holjevac J, Radic B, Turudic T, Kokot A, Patrlj L, Rucman R, Seiwerth S, Sikiric PStable gastric pentadecapeptide BPC 157 heals cysteamine-colitis and colon-colon-anastomosis and counteracts cuprizone brain injuries and motor disabilityJ Physiol Pharmacol.(2013 Oct)
16.^Torkildsen O, Brunborg LA, Myhr KM, Bø LThe cuprizone model for demyelinationActa Neurol Scand Suppl.(2008)
17.^Herring NR, Konradi CMyelin, copper, and the cuprizone model of schizophreniaFront Biosci (Schol Ed).(2011 Jan 1)
18.^Benetti F, Ventura M, Salmini B, Ceola S, Carbonera D, Mammi S, Zitolo A, D'Angelo P, Urso E, Maffia M, Salvato B, Spisni ECuprizone neurotoxicity, copper deficiency and neurodegenerationNeurotoxicology.(2010 Sep)
22.^Staresinic M, Sebecic B, Patrlj L, Jadrijevic S, Suknaic S, Perovic D, Aralica G, Zarkovic N, Borovic S, Srdjak M, Hajdarevic K, Kopljar M, Batelja L, Boban-Blagaic A, Turcic I, Anic T, Seiwerth S, Sikiric PGastric pentadecapeptide BPC 157 accelerates healing of transected rat Achilles tendon and in vitro stimulates tendocytes growthJ Orthop Res.(2003 Nov)
23.^Sikirić P, Mazul B, Seiwerth S, Grabarević Z, Rucman R, Petek M, Jagić V, Turković B, Rotkvić I, Mise S, Zoricić I, Jurina L, Konjevoda P, Hanzevacki M, Gjurasin M, Separović J, Ljubanović D, Artuković B, Bratulić M, Tisljar M, Miklić P, Sumajstorcić JPentadecapeptide BPC 157 interactions with adrenergic and dopaminergic systems in mucosal protection in stressDig Dis Sci.(1997 Mar)
24.^Luetic K, Sucic M, Vlainic J, Halle ZB, Strinic D, Vidovic T, Luetic F, Marusic M, Gulic S, Pavelic TT, Kokot A, Seiwerth RS, Drmic D, Batelja L, Seiwerth S, Sikiric PCyclophosphamide induced stomach and duodenal lesions as a NO-system disturbance in rats: L-NAME, L-arginine, stable gastric pentadecapeptide BPC 157Inflammopharmacology.(2017 Apr)
25.^Bilic I, Zoricic I, Anic T, Separovic J, Stancic-Rokotov D, Mikus D, Buljat G, Ivankovic D, Aralica G, Prkacin I, Perovic D, Mise S, Rotkvic I, Petek M, Rucman R, Seiwerth S, Sikiric PHaloperidol-stomach lesions attenuation by pentadecapeptide BPC 157, omeprazole, bromocriptine, but not atropine, lansoprazole, pantoprazole, ranitidine, cimetidine and misoprostol in miceLife Sci.(2001 Mar 9)
26.^Sikiric P, Seiwerth S, Aralica G, Perovic D, Staresinic M, Anic T, Gjurasin M, Prkacin I, Separovic J, Stancic-Rokotov D, Lovric-Bencic M, Mikus D, Turkovic B, Rotkvic I, Mise S, Rucman R, Petek M, Ziger T, Sebecic B, Ivasovic Z, Jagic V, Komericki L, Balen I, Boban-Blagaic A, Sjekavica ITherapy effect of antiulcer agents on new chronic cysteamine colon lesion in ratJ Physiol Paris.(2001 Jan-Dec)
27.^Sikiric P, Seiwerth S, Grabarevic Z, Balen I, Aralica G, Gjurasin M, Komericki L, Perovic D, Ziger T, Anic T, Prkacin I, Separovic J, Stancic-Rokotov D, Lovric-Bencic M, Mikus D, Staresinic M, Aralica J, DiBiaggio N, Simec Z, Turkovic B, Rotkvic I, Mise S, Rucman R, Petek M, Sebecic B, Ivasovic Z, Boban-Blagaic A, Sjekavica ICysteamine-colon and cysteamine-duodenum lesions in rats. Attenuation by gastric pentadecapeptide BPC 157, cimetidine, ranitidine, atropine, omeprazole, sulphasalazine and methylprednisoloneJ Physiol Paris.(2001 Jan-Dec)
28.^Sikiric P, Seiwerth S, Rucman R, Turkovic B, Rokotov DS, Brcic L, Sever M, Klicek R, Radic B, Drmic D, Ilic S, Kolenc D, Stambolija V, Zoricic Z, Vrcic H, Sebecic BFocus on ulcerative colitis: stable gastric pentadecapeptide BPC 157Curr Med Chem.(2012)
29.^Hrelec M, Klicek R, Brcic L, Brcic I, Cvjetko I, Seiwerth S, Sikiric PAbdominal aorta anastomosis in rats and stable gastric pentadecapeptide BPC 157, prophylaxis and therapyJ Physiol Pharmacol.(2009 Dec)
30.^Djakovic Z, Djakovic I, Cesarec V, Madzarac G, Becejac T, Zukanovic G, Drmic D, Batelja L, Zenko Sever A, Kolenc D, Pajtak A, Knez N, Japjec M, Luetic K, Stancic-Rokotov D, Seiwerth S, Sikiric PEsophagogastric anastomosis in rats: Improved healing by BPC 157 and L-arginine, aggravated by L-NAMEWorld J Gastroenterol.(2016 Nov 7)
31.^Grgic T, Grgic D, Drmic D, Sever AZ, Petrovic I, Sucic M, Kokot A, Klicek R, Sever M, Seiwerth S, Sikiric PStable gastric pentadecapeptide BPC 157 heals rat colovesical fistulaEur J Pharmacol.(2016 Jun 5)
32.^Baric M, Sever AZ, Vuletic LB, Rasic Z, Sever M, Drmic D, Pavelic-Turudic T, Sucic M, Vrcic H, Seiwerth S, Sikiric PStable gastric pentadecapeptide BPC 157 heals rectovaginal fistula in ratsLife Sci.(2016 Mar 1)
33.^Vuksic T, Zoricic I, Brcic L, Sever M, Klicek R, Radic B, Cesarec V, Berkopic L, Keller N, Blagaic AB, Kokic N, Jelic I, Geber J, Anic T, Seiwerth S, Sikiric PStable gastric pentadecapeptide BPC 157 in trials for inflammatory bowel disease (PL-10, PLD-116, PL14736, Pliva, Croatia) heals ileoileal anastomosis in the ratSurg Today.(2007)
34.^Sever M, Klicek R, Radic B, Brcic L, Zoricic I, Drmic D, Ivica M, Barisic I, Ilic S, Berkopic L, Blagaic AB, Coric M, Kolenc D, Vrcic H, Anic T, Seiwerth S, Sikiric PGastric pentadecapeptide BPC 157 and short bowel syndrome in ratsDig Dis Sci.(2009 Oct)
36.^Sikiric P, Marovic A, Matoz W, Anic T, Buljat G, Mikus D, Stancic-Rokotov D, Separovic J, Seiwerth S, Grabarevic Z, Rucman R, Petek M, Ziger T, Sebecic B, Zoricic I, Turkovic B, Aralica G, Perovic D, Duplancic B, Lovric-Bencic M, Rotkvic I, Mise S, Jagic V, Hahn VA behavioural study of the effect of pentadecapeptide BPC 157 in Parkinson's disease models in mice and gastric lesions induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydrophyridineJ Physiol Paris.(1999 Dec)